Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Alembic Pharma’s approves NCDs up to Rs 300 crore

expressbpdJune 14, 2019

Tag: Alembic Pharma , NCDs , Shares

PharmaSources Customer Service